SCHEMBL6760435

SCHEMBL6760435

Cc1ncc(-c2cc(Cl)cc(NC(=O)c3cccc4c3[nH]c3ccccc34)c2)n1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 5/20 0.45
GRM5 P41594 1/20 0.42
KMT2A Q03164 6/20 0.39
MEN1 O00255 5/20 0.39
LMNA P02545 1/20 0.39
POLB P06746 1/20 0.39
GSK3B P49841 2/20 0.39
MAPT P10636 2/20 0.39
KDM4E B2RXH2 2/20 0.39
GAA P10253 1/20 0.39
ICOSLG O75144 1/20 0.39
ICOS Q9Y6W8 1/20 0.39
IDO1 P14902 1/20 0.39
KDR P35968 1/20 0.38
TDO2 P48775 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CCKBR P32239 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6760168 0.91 DYRK1A (0.41) DYRK1AGRM5GSK3BICOSLGICOS
SCHEMBL6803727 0.89 DYRK1A (0.46) DYRK1AGRM5KMT2AMEN1LMNA
SCHEMBL6756890 0.88 DYRK1A (0.44) DYRK1AGRM5KMT2AMEN1GSK3B
SCHEMBL6755637 0.88 MAPT (0.45) DYRK1AKMT2AMEN1GSK3BMAPT
SCHEMBL6755618 0.80 DYRK1A (0.40) DYRK1AGRM5KMT2AMEN1GSK3B
SCHEMBL6804372 0.80 DYRK1A (0.45) DYRK1AKMT2AMEN1GSK3BMAPT
SCHEMBL6756978 0.78 KMT2A (0.43) GRM5KMT2AMEN1LMNAPOLB
SCHEMBL6756628 0.78 KMT2A (0.43) GRM5KMT2AMEN1LMNAPOLB
SCHEMBL6757933 0.77 SCN4A (0.42) DYRK1AGRM5KMT2AMEN1LMNA
SCHEMBL6754360 0.77 DYRK1A (0.45) DYRK1AGRM5KMT2AMEN1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040087798-A1 Novel amide compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-05-06 US disclosed
EP-1264820-A1 NOVEL AMIDE COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-12-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040087798-A1 Novel amide compounds H1-2, H1-0, H1-3 DYRK1A 3409/4885GRM5 1930/4885KMT2A 130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.